Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 21 Oct 2022 for ONCODESIGN, €262k. Read the official filing
Filing timeline
BuySaleThierry Billoue
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thierry Billoue: trading record in brief
Thierry Billoue discloses dealings in Oncodesign to AMF. Between 7 October 2022 and 18 October 2022, the trades on record add up to 2 filings.
Market trades split into 1 purchase (€101k) and 1 sale (€262k). Netting one side against the other leaves €161k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 21 October 2022: an open-market sale of €262k, in Oncodesign. The clock since the last published purchase (10 October 2022) now reads 1,468 days. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thierry Billoue
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
18,140 shares@ €14.4272.2% of flowActionHors plateforme de négociationISIN FR00117662292022DD867537
10,080 shares@ €10.0027.8% of flowActionEuronext ParisISIN FR00117662292022DD865660
Canonical exit: 5 Jan 2023 (T+90)
2 of 2 declarations
